UiPath stock has tumbled as optimism around its automation software has been overtaken by concern about artificial intelligence.

UiPath reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for ...

UiPath (NYSE:PATH) declined approximately 6% in today’s session, trading below $12 midday on Thursday. The selloff is puzzling on the surface. UiPath just posted a quarter that beat expectations on ...

UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

UiPath (NYSE:PATH) and Deloitte have expanded their alliance, introducing Deloitte's Agentic ERP offering with UiPath's ...

Enterprise automation budgets are shifting from point tools to platforms. Buyers want governance, reuse, and faster time to ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

Founded in Romania in 2005, UiPath develops AI software that is able to automate boring activities like extracting data, filling documents, or updating databases. The fast-growing market of Robotic ...

Best AI Software Products Best Agentic AI Software Products Best Development Software Products Best IT Management Software Products Best Global Software Companies “We’re grateful for the trust our ...

Every technology company wants a slice of the Artificial Intelligence (AI) pie. More accurately, every tech company wants to show that it has a healthy AI development stream bringing the benefits of ...